Burning Rock Biotech Limited (BNR) NASDAQ
16.20
-0.1(-0.61%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
16.20
-0.1(-0.61%)
Currency In USD
| Market Cap | 151.96M |
| Enterprise Value | -286.28M |
| P/E Ratio | -2.12 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0.22 |
| Price/Book Ratio | 0.22 |
| Enterprise/Revenue | -0.59 |
| Enterprise/EBITDA | 12.16 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.1 |
| Operating Margin | -0.1 |
| Return On Assets | -0.07 |
| Return On Equity | -0.1 |
| Revenue | 524.87M |
| Revenue/Share | 513.34 |
| Gross Profit | 391.94M |
| EBITDA | -43.05M |
| Net Income | -53.84M |
| Diluted EPS | -49.6 |
| Total Cash | 481.39M |
| Total Cash/Share | 459.48 |
| Total Debt | 43.15M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 2.99 |
| Book Value Per Share | 511.22 |
| 52-Week Change | 310.13 |
| 52-Week High | 41.72 |
| 52-Week Low | 2.18 |
| Moving Average 50 Days | 26.17 |
| Moving Average 200 Days | 15.2 |
| Average Volume | 28,829 |
| Shares Outstanding | 1.08M |
| % Held by Institutions | 158.82 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | May 15, 2024 |